Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aritro Nath

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Molecular Cancer Research : MCR|October 27, 2020
Palmitate-Induced IRE1-XBP1-ZEB Signaling Represses Desmoplakin Expression and Promotes Cancer Cell MigrationAritro Nath, Amrita Oak, Kevin Y Chen, et al.
Genome Biology|September 13, 2018
Cancer expression quantitative trait loci (eQTLs) can be determined from heterogeneous tumor gene expression data by modeling variation in tumor purityPaul Geeleher, Aritro Nath, Fan Wang, et al.
Nature Communications|March 3, 2025
Cellular interactions within the immune microenvironment underpins resistance to cell cycle inhibition in breast cancersJason I Griffiths, Patrick A Cosgrove, Eric F Medina, et al.
Nature Communications|June 29, 2023
Cell facilitation promotes growth and survival under drug pressure in breast cancerRena Emond, Jason I Griffiths, Vince Kornél Grolmusz, et al.
Translational Oncology|November 22, 2020
A `one-two punch' therapy strategy to target chemoresistance in estrogen receptor positive breast cancerFeng Chi, Jiayi Liu, Samuel W Brady, et al.
The Journal of Biological Chemistry|August 23, 2015
Rapid fine conformational epitope mapping using comprehensive mutagenesis and deep sequencingCaitlin A Kowalsky, Matthew S Faber, Aritro Nath, et al.
Molecular Systems Biology|May 9, 2025
Blocking cancer-fibroblast mutualism inhibits proliferation of endocrine therapy resistant breast cancerJason I Griffiths, Feng Chi, Elena Farmaki, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|February 28, 2022
RAGE Inhibitors as Alternatives to Dexamethasone for Managing Cerebral Edema Following Brain Tumor SurgeryShunan Liu, Yanyan Song, Ian Y Zhang, et al.
NPJ Precision Oncology|December 14, 2025
Divergent oncogenic signaling and immune microenvironment changes in low-grade serous ovarian cancer patients undergoing intraperitoneal chemotherapyIsaac Bishara, Patrick A Cosgrove, Sumana Majumdar, et al.
Haematologica|June 18, 2026
Dual CDK2 and CDK4/6 inhibition suppresses Rb/E2F signaling and enhances anti-leukemic activity in acute myeloid leukemiaEllen Weisberg, Basudev Chowdhury, Swati Garg, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Molecular Cancer Research : MCR|October 27, 2020
Palmitate-Induced IRE1-XBP1-ZEB Signaling Represses Desmoplakin Expression and Promotes Cancer Cell MigrationAritro Nath, Amrita Oak, Kevin Y Chen, et al.
Genome Biology|September 13, 2018
Cancer expression quantitative trait loci (eQTLs) can be determined from heterogeneous tumor gene expression data by modeling variation in tumor purityPaul Geeleher, Aritro Nath, Fan Wang, et al.
Nature Communications|March 3, 2025
Cellular interactions within the immune microenvironment underpins resistance to cell cycle inhibition in breast cancersJason I Griffiths, Patrick A Cosgrove, Eric F Medina, et al.
Nature Communications|June 29, 2023
Cell facilitation promotes growth and survival under drug pressure in breast cancerRena Emond, Jason I Griffiths, Vince Kornél Grolmusz, et al.
Translational Oncology|November 22, 2020
A `one-two punch' therapy strategy to target chemoresistance in estrogen receptor positive breast cancerFeng Chi, Jiayi Liu, Samuel W Brady, et al.
The Journal of Biological Chemistry|August 23, 2015
Rapid fine conformational epitope mapping using comprehensive mutagenesis and deep sequencingCaitlin A Kowalsky, Matthew S Faber, Aritro Nath, et al.
Molecular Systems Biology|May 9, 2025
Blocking cancer-fibroblast mutualism inhibits proliferation of endocrine therapy resistant breast cancerJason I Griffiths, Feng Chi, Elena Farmaki, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|February 28, 2022
RAGE Inhibitors as Alternatives to Dexamethasone for Managing Cerebral Edema Following Brain Tumor SurgeryShunan Liu, Yanyan Song, Ian Y Zhang, et al.
NPJ Precision Oncology|December 14, 2025
Divergent oncogenic signaling and immune microenvironment changes in low-grade serous ovarian cancer patients undergoing intraperitoneal chemotherapyIsaac Bishara, Patrick A Cosgrove, Sumana Majumdar, et al.
Haematologica|June 18, 2026
Dual CDK2 and CDK4/6 inhibition suppresses Rb/E2F signaling and enhances anti-leukemic activity in acute myeloid leukemiaEllen Weisberg, Basudev Chowdhury, Swati Garg, et al.
Pageof 5